
### [MONDO:0005083](http://purl.obolibrary.org/obo/MONDO_0005083)
**Label:** psoriasis

**Subclasses:** [MONDO:0013057](http://purl.obolibrary.org/obo/MONDO_0013057) (PSORS12), [MONDO:0011084](http://purl.obolibrary.org/obo/MONDO_0011084) (PSORS3), [MONDO:0008251](http://purl.obolibrary.org/obo/MONDO_0008251) (pityriasis rubra pilaris), [MONDO:0013554](http://purl.obolibrary.org/obo/MONDO_0013554) (psoriasis 13, susceptibility to), [MONDO:0012542](http://purl.obolibrary.org/obo/MONDO_0012542) (PSORS8), [MONDO:0011387](http://purl.obolibrary.org/obo/MONDO_0011387) (PSORS4), [MONDO:0014494](http://purl.obolibrary.org/obo/MONDO_0014494) (psoriasis 15, pustular, susceptibility to), [MONDO:0011573](http://purl.obolibrary.org/obo/MONDO_0011573) (PSORS7), [MONDO:0016597](http://purl.obolibrary.org/obo/MONDO_0016597) (generalized pustular psoriasis), [MONDO:0018452](http://purl.obolibrary.org/obo/MONDO_0018452) (DITRA), [MONDO:0008334](http://purl.obolibrary.org/obo/MONDO_0008334) (psoriasis 1, susceptibility to), [MONDO:0011926](http://purl.obolibrary.org/obo/MONDO_0011926) (PSORS9), [MONDO:0012959](http://purl.obolibrary.org/obo/MONDO_0012959) (PSORS11), [MONDO:0011269](http://purl.obolibrary.org/obo/MONDO_0011269) (psoriasis 2), [MONDO:0013626](http://purl.obolibrary.org/obo/MONDO_0013626) (psoriasis 14, pustular), [MONDO:0011434](http://purl.obolibrary.org/obo/MONDO_0011434) (PSORS5), [MONDO:0012896](http://purl.obolibrary.org/obo/MONDO_0012896) (PSORS10), [MONDO:0011542](http://purl.obolibrary.org/obo/MONDO_0011542) (PSORS6), 

**Corr. equiv. classes:** [OMIM:607857](http://purl.obolibrary.org/obo/OMIM_607857), [OMIM:610707](http://purl.obolibrary.org/obo/OMIM_610707), [OMIM:604316](http://purl.obolibrary.org/obo/OMIM_604316), [OMIM:601454](http://purl.obolibrary.org/obo/OMIM_601454), [Orphanet:404546](http://www.orpha.net/ORDO/Orphanet_404546), [OMIM:603935](http://purl.obolibrary.org/obo/OMIM_603935), [OMIM:614070](http://purl.obolibrary.org/obo/OMIM_614070), [OMIM:602723](http://purl.obolibrary.org/obo/OMIM_602723), [OMIM:605606](http://purl.obolibrary.org/obo/OMIM_605606), [Orphanet:2897](http://www.orpha.net/ORDO/Orphanet_2897), [OMIM:177900](http://purl.obolibrary.org/obo/OMIM_177900), [OMIM:173200](http://purl.obolibrary.org/obo/OMIM_173200), [Orphanet:247353](http://www.orpha.net/ORDO/Orphanet_247353), [OMIM:612950](http://purl.obolibrary.org/obo/OMIM_612950), [OMIM:612410](http://purl.obolibrary.org/obo/OMIM_612410), [OMIM:616106](http://purl.obolibrary.org/obo/OMIM_616106), [OMIM:614204](http://purl.obolibrary.org/obo/OMIM_614204), [OMIM:612599](http://purl.obolibrary.org/obo/OMIM_612599), [OMIM:605364](http://purl.obolibrary.org/obo/OMIM_605364), 

**Class expressions from DL-Learner:**

- [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 18.93%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 18.72%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 18.61%
- [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 18.41%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) 18.17%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 17.89%
- [HP:0001597](http://purl.obolibrary.org/obo/HP_0001597) (Abnormality of the nail) 17.75%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 17.04%
- Thing 17.03%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 17.03%
- [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 16.83%
- [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 16.83%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 16.08%
- [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 15.89%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 15.72%


